Removing chromatography from mass spectrometry reshapes how laboratories approach screening and detection. Direct mass spectrometry workflows capture data instantly, enabling analysts to exploit the sensitivity and selectivity of modern MS systems without the delays imposed by separations. As Terry Bates, Founder and CEO of Quantera Analytical, explains, this shift proves especially relevant for emerging analytical challenges such as novel psychoactive substances (NPS), where speed and adaptability determine effectiveness.
Direct analysis strategies allow laboratories to expand screening panels quickly and respond to new compounds with minimal method redevelopment. The approach supports sensitive, selective detection while simplifying workflows and reducing analytical bottlenecks. As NPS markets evolve, laboratories require techniques that keep pace with rapid compound turnover and growing surveillance demands.
By prioritizing instantaneous measurement and agile method design, direct mass spectrometry offers a practical path toward faster detection, improved coverage, and stronger analytical responsiveness.
